Lanx draws $8.7M for spinal fusion device development

Lanx, a Colorado maker of spinal fusion devices, has pulled in $8.7 million in new funding. Chief Financial Officer Steve Deitsch told MedCity News that the money will be used, in part, to boost marketing of its Timberline lateral fusion system, which debuted in February. Funding will also support bringing as many as 6 new products to market in 2016. The funding round isn't complete, however. According to the story, Lanx wants to raise $15.1 million overall. Story

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.